John‐Paul Vermitsky

796 total citations
9 papers, 616 citations indexed

About

John‐Paul Vermitsky is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, John‐Paul Vermitsky has authored 9 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 1 paper in Molecular Biology. Recurrent topics in John‐Paul Vermitsky's work include Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). John‐Paul Vermitsky is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). John‐Paul Vermitsky collaborates with scholars based in United States and France. John‐Paul Vermitsky's co-authors include Thomas D. Edlind, P. David Rogers, Ramin Homayouni, William Smith, Scott E. Gygax, Sean G. Chadwick, Eli Mordechai, Martin E. Adelson, Jason P. Trama and Säntosh K. Katiyar and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Molecular Microbiology.

In The Last Decade

John‐Paul Vermitsky

9 papers receiving 599 citations

Peers

John‐Paul Vermitsky
Laurence F. Mirels United States
A Viudes Spain
Kristy Koselny United States
Abdullah Alqarihi United States
Craig L. Ennis United States
Guanpingsheng Luo United States
Padmaja Paderu United States
John‐Paul Vermitsky
Citations per year, relative to John‐Paul Vermitsky John‐Paul Vermitsky (= 1×) peers Nadja Jablonowski

Countries citing papers authored by John‐Paul Vermitsky

Since Specialization
Citations

This map shows the geographic impact of John‐Paul Vermitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John‐Paul Vermitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John‐Paul Vermitsky more than expected).

Fields of papers citing papers by John‐Paul Vermitsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John‐Paul Vermitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John‐Paul Vermitsky. The network helps show where John‐Paul Vermitsky may publish in the future.

Co-authorship network of co-authors of John‐Paul Vermitsky

This figure shows the co-authorship network connecting the top 25 collaborators of John‐Paul Vermitsky. A scholar is included among the top collaborators of John‐Paul Vermitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John‐Paul Vermitsky. John‐Paul Vermitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Katiyar, Säntosh K., et al.. (2016). Evaluation of Polymorphic Locus Sequence Typing for Candida glabrata Epidemiology. Journal of Clinical Microbiology. 54(4). 1042–1050. 14 indexed citations
2.
Whaley, Sarah, Kelly E. Caudle, John‐Paul Vermitsky, et al.. (2014). UPC2A Is Required for High-Level Azole Antifungal Resistance in Candida glabrata. Antimicrobial Agents and Chemotherapy. 58(8). 4543–4554. 41 indexed citations
3.
Chadwick, Sean G., Jessica A. Schuyler, John‐Paul Vermitsky, et al.. (2013). X-Plate Technology: a new method for detecting fluconazole resistance in Candida species. Journal of Medical Microbiology. 62(5). 720–726. 6 indexed citations
4.
Steier, Zoë, John‐Paul Vermitsky, Geoffrey Toner, et al.. (2013). Flucytosine Antagonism of Azole Activity versus Candida glabrata: Role of Transcription Factor Pdr1 and Multidrug Transporter Cdr1. Antimicrobial Agents and Chemotherapy. 57(11). 5543–5547. 13 indexed citations
5.
Vermitsky, John‐Paul, Sean G. Chadwick, Jason P. Trama, et al.. (2008). Survey of Vaginal-Flora Candida Species Isolates from Women of Different Age Groups by Use of Species-Specific PCR Detection. Journal of Clinical Microbiology. 46(4). 1501–1503. 94 indexed citations
6.
Gygax, Scott E., John‐Paul Vermitsky, Sean G. Chadwick, et al.. (2008). Antifungal Resistance of Candida glabrata Vaginal Isolates and Development of a Quantitative Reverse Transcription-PCR-Based Azole Susceptibility Assay. Antimicrobial Agents and Chemotherapy. 52(9). 3424–3426. 16 indexed citations
7.
Vermitsky, John‐Paul, et al.. (2006). Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies. Molecular Microbiology. 61(3). 704–722. 180 indexed citations
8.
Edlind, Thomas D., et al.. (2005). Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast. Current Genetics. 48(2). 117–125. 31 indexed citations
9.
Vermitsky, John‐Paul & Thomas D. Edlind. (2004). Azole Resistance in Candida glabrata : Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor. Antimicrobial Agents and Chemotherapy. 48(10). 3773–3781. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026